Prabhat Dairy (PRABHAT) – Among all the listed dairy plays, Prabhat stands out; relatively low capex, and better brand potency. Resultantly, it has been our top pick in the sector. Reassuringly, Q1 revenue grew by 23% YoY aided by value added products which now constitute 85% of sales. Gross margin increased 210bps yoy to 20.9% aided by higher realization in consumer business. We retain BUY with TP of INR145.
Bluestar (BLSTR) – Strong quarter with increase in revenue by 20% YoY. While the market for room air conditioners (RAC) remained flat, BLSTR grew by 7% yoy with a gain in market share of 50bps yoy to 11%. In the VRF and inverter AC segments, BLSTR grew by 20% and 24% yoy, respectively. Slight disappointment was in EBITDAM which declined by 50bps due to PEIS and UP segment. We maintain Reduce, but that is because of our no-belief in the business performance beyond FY20..
Cadila (CDH) – To start with : Q1FY18 result is disappointing. Reason : significant underperformance in the India business and continued pricing pressure in the US market. All is not lost though , CDH has provided a strong launch outlook, including switch of own gAsacol HD, gPrevacid ODT, gToprol XL as well as commercialization of the transdermal portfolio. Sitting on our perch, and looking two years into future : robust launch outlook will drive strong earnings growth over the next 2 years, and a low base will also be supportive. As a meta theme, we see a strong cyclical recovery in earnings for generic companies, but continue to believe that structural underpinnings remain weaker than ever. Maintain HOLD rating, valuing CDH at PE of 18x FY19E EPS of Rs26.
Sadbhav Engineering (SADE) - SADE reported revenue of Rs9.4bn (up 17% YoY) and EBITDA of ~Rs1.1bn (up 23% YoY) better than our expectations of Rs8.9bn and Rs0.9bn respectively. Standalone debt level has reduced by Rs2bn QoQ to Rs14.5bn mainly owing to receipt of mobilization advance and reduction in debtors. Mining segment execution which had come to a halt is likely to revive and start contributing substantially Q3FY18 onwards as service tax issue has been resolved. We continue to retain our estimates and maintain Buy rating on the stock with a revised SOTP based TP of Rs378 valuing the standalone EPC business at Rs244 on 18x FY19E EPS of Rs13.5 and Rs135 for SIPL based on current market cap and giving a 10% holding company discount.
Aditya Birla Capital (ABCL) – No listing timeline defined. Aims to grow faster than market for both NBFC as well as HFC (25-30% in medium term). Targets 15% RoEs in HFC in next two years. Aiming to launch consumer finance business by H2FY18. At current growth rates, the company may require Rs7-8bn of growth capital in FY18 – which will be provided by the stake sale done to Premji Invest (Rs7.04bn yet to be received).
Comments
Post a Comment